Skip to content

Healthcare Services Group HCSG Payments to Acquire Equity Method Investments

Payments to Acquire Equity Method Investments at other companies

Aramark logo
AramarkARMK

Other financials

Income statement

See full
Revenue$462.8M+3.4%
Gross profit$75.8M+11.6%
Net income$26.1M+51.3%
EPS (diluted)$0.37+60.9%

Balance sheet

See full
Cash & equivalents$136.2M+112%
Total debt$14.7M-11.1%
Total equity$513.8M-0.1%
Total assets$814.8M-1.0%

Cash flow

See full
Operating cash flow$43.7M+59.0%
CapEx$1.4M-19.8%
Free cash flow$42.3M+64.3%

Valuation

See full
Market cap$1.55B+76.0%
Enterprise value$1.43B+70.6%
P/E22.9×+1.6×
P/S0.8×+0.3×

Profitability

See full
Gross margin13.3%0.0pp
Net margin3.7%+1.3pp
FCF margin8.4%

Returns & leverage

See full
Return on equity13.2%+4.8pp
Debt / equity0.0×
Current ratio3.1×+0.2×

Where this comes from

Reported directly by Healthcare Services Group in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireEquityMethodInvestments.

The official record: Healthcare Services Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Healthcare Services Group's payments to acquire equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Healthcare Services Group's payments to acquire equity method investments?
Healthcare Services Group (HCSG) reported payments to acquire equity method investments of $4.58M in Q1 2026.
How has Healthcare Services Group's payments to acquire equity method investments changed year-over-year?
Healthcare Services Group's payments to acquire equity method investments increased by 115.3% year-over-year, from $2.13M to $4.58M.
What does payments to acquire equity method investments mean?
Represents cash outflows used to acquire interests in entities where the company exercises significant influence but does not have full control. This metric reflects the company's strategy for inorganic growth and strategic partnerships through non-consolidated investments.